This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Hodges, Y. K. Articles by Horwitz, L. D. Search for Related Content PubMed PubMed Citation Articles by Hodges, Y. K. Articles by Horwitz, L. D. Related Collections Gene expression Physiological and pathological control of gene expression

(Circulation. 1999;99:2688-2693.)
© 1999 American Heart Association, Inc.

Basic Science Reports

Variant Estrogen and Progesterone Receptor Messages in Human Vascular Smooth Muscle

Yvonne K. Hodges, PhD; Jennifer K. Richer, PhD; Kathryn B. Horwitz, PhD; Lawrence D. Horwitz, MD

From the Department of Medicine, Division of Cardiology (Y.K.H., L.D.H.) and Division of Endocrinology (J.K.R., K.B.H.), University of Colorado Health Sciences Center, Denver, Colo.

Correspondence to Lawrence D. Horwitz, MD, Cardiology B130, University of Colorado Health Sciences Center, Denver, CO 80262. E-mail lawrence.horwitz{at}uchsc.edu

Background—Estrogens stimulate growth of breast or uterine cells but have the opposite effect on vascular smooth muscle cells, in which they protect against coronary artery disease with or without concomitant administration of progesterone. A possible cause of differences in hormone action is variable tissue-specific expression of hormone receptor. Therefore, we analyzed the structure of estrogen receptors (ERs) and progesterone receptors (PRs) in human vascular smooth muscle.

Methods and Results—RNA was isolated from human vascular smooth muscle, and the functional domains of ER- and PR were characterized by reverse transcriptase and polymerase chain reaction. Interestingly, in addition to wild-type ER- and PR, 5 variant ER- and 2 variant PR transcripts were found. These variants contained precise deletions of exons encoding regions of the hormone-binding domain. The PR transcripts lacked exon 4 (PR4) and exon 6 (PR6). The ER- transcripts were missing exon 4 (ER4), exon 5 (ER5), exon 6 (ER6), exon 7 (ER7), and exons 6 and 7, (ER6,7). ER-ß variants were also detected. The PR variants were functionally characterized, and PR6 was found to be a dominant-negative transcription inhibitor of wild-type receptors. Variant PR was present in premenopausal women but absent in postmenopausal women.

Conclusions—Variant PR and ER transcripts are extensively expressed in human vascular smooth muscle. The complex tissue-specific effects of sex hormones may be mediated by the expression of heterogeneous forms of their cognate receptors. The presence of variant ERs and PRs may be of importance in altering the physiological effects of estrogens or progestins in vascular smooth muscle.

Key Words: genes • muscle, smooth • receptors • hormones • coronary disease

This article has been cited by other articles:

				R. Sheshgiri, V. Rao, L. C. Tumiati, R. Xiao, J. L. Prodger, M. Badiwala, C. Librach, and D. H. Delgado Progesterone Induces Human Leukocyte Antigen-G Expression in Vascular Endothelial and Smooth Muscle Cells Circulation, September 30, 2008; 118(14_suppl_1): S58 - S64. [Abstract] [Full Text] [PDF]

				M. Schumacher, R. Guennoun, A. Ghoumari, C. Massaad, F. Robert, M. El-Etr, Y. Akwa, K. Rajkowski, and E.-E. Baulieu Novel Perspectives for Progesterone in Hormone Replacement Therapy, with Special Reference to the Nervous System Endocr. Rev., June 1, 2007; 28(4): 387 - 439. [Abstract] [Full Text] [PDF]

				C M. Luetjens, A. Didolkar, S. Kliesch, W. Paulus, A. Jeibmann, W. Bocker, E. Nieschlag, and M. Simoni Tissue expression of the nuclear progesterone receptor in male non-human primates and men. J. Endocrinol., June 1, 2006; 189(3): 529 - 539. [Abstract] [Full Text] [PDF]

				T. M. Price, E. L. Hansen, and T. N. Oliver Immunofluorescent Localization of a Novel Progesterone Receptor(s) in a T47D-Y Breast Cancer Cell Line Lacking Genomic Progesterone Receptor Expression Reproductive Sciences, December 1, 2005; 12(8): 610 - 616. [Abstract] [PDF]

				W. X. Liao, R. R. Magness, and D.-b. Chen Expression of Estrogen Receptors-{alpha} and -{beta} in the Pregnant Ovine Uterine Artery Endothelial Cells In Vivo and In Vitro Biol Reprod, March 1, 2005; 72(3): 530 - 537. [Abstract] [Full Text] [PDF]

				S. C. E. Schuit, H.-H. S. Oei, J. C. M. Witteman, C. H. Geurts van Kessel, J. B. J. van Meurs, R. L. Nijhuis, J. P. T. M. van Leeuwen, F. H. de Jong, M. C. Zillikens, A. Hofman, et al. Estrogen Receptor {alpha} Gene Polymorphisms and Risk of Myocardial Infarction JAMA, June 23, 2004; 291(24): 2969 - 2977. [Abstract] [Full Text] [PDF]

				A. Pollak, A. Rokach, A. Blumenfeld, L. J Rosen, L. Resnik, and R. Dresner Pollak Association of oestrogen receptor alpha gene polymorphism with the angiographic extent of coronary artery disease Eur. Heart J., February 1, 2004; 25(3): 240 - 245. [Abstract] [Full Text] [PDF]

				B. H. Welter, E. L. Hansen, K. J. Saner, Y. Wei, and T. M. Price Membrane-bound Progesterone Receptor Expression in Human Aortic Endothelial Cells J. Histochem. Cytochem., August 1, 2003; 51(8): 1049 - 1055. [Abstract] [Full Text]

				S. J. Elliot, M. Karl, M. Berho, M. Potier, F. Zheng, B. Leclercq, G. E. Striker, and L. J. Striker Estrogen Deficiency Accelerates Progression of Glomerulosclerosis in Susceptible Mice Am. J. Pathol., May 1, 2003; 162(5): 1441 - 1448. [Abstract] [Full Text] [PDF]

				D. M. Herrington, T. D. Howard, G. A. Hawkins, D. M. Reboussin, J. Xu, S. L. Zheng, K. B. Brosnihan, D. A. Meyers, and E. R. Bleecker Estrogen-Receptor Polymorphisms and Effects of Estrogen Replacement on High-Density Lipoprotein Cholesterol in Women with Coronary Disease N. Engl. J. Med., March 28, 2002; 346(13): 967 - 974. [Abstract] [Full Text] [PDF]

				D. M. Herrington and K. P. Klein Genome and Hormones: Gender Differences in Physiology: Invited Review: Pharmacogenetics of estrogen replacement therapy J Appl Physiol, December 1, 2001; 91(6): 2776 - 2784. [Abstract] [Full Text] [PDF]

				R. K. Dubey and E. K. Jackson Estrogen-induced cardiorenal protection: potential cellular, biochemical, and molecular mechanisms Am J Physiol Renal Physiol, March 1, 2001; 280(3): F365 - F388. [Abstract] [Full Text] [PDF]

				M. POTIER, S. J. ELLIOT, I. TACK, O. LENZ, G. E. STRIKER, L. J. STRIKER, and M. KARL Expression and Regulation of Estrogen Receptors in Mesangial Cells: Influence on Matrix Metalloproteinase-9 J. Am. Soc. Nephrol., February 1, 2001; 12(2): 241 - 251. [Abstract] [Full Text]

				G. B. Stefano, P. Cadet, C. Breton, Y. Goumon, V. Prevot, J. P. Dessaint, J.-C. Beauvillain, A. S. Roumier, I. Welters, and M. Salzet Estradiol-stimulated nitric oxide release in human granulocytes is dependent on intracellular calcium transients: evidence of a cell surface estrogen receptor Blood, June 15, 2000; 95(12): 3951 - 3958. [Abstract] [Full Text] [PDF]

				Y. K. Hodges, L. Tung, X.-D. Yan, J. D. Graham, K. B. Horwitz, and L. D. Horwitz Estrogen Receptors {alpha} and {beta} : Prevalence of Estrogen Receptor {beta} mRNA in Human Vascular Smooth Muscle and Transcriptional Effects Circulation, April 18, 2000; 101(15): 1792 - 1798. [Abstract] [Full Text] [PDF]

				G. B. Stefano, V. Prevot, J.-C. Beauvillain, P. Cadet, C. Fimiani, I. Welters, G. L. Fricchione, C. Breton, P. Lassalle, M. Salzet, et al. Cell-Surface Estrogen Receptors Mediate Calcium-Dependent Nitric Oxide Release in Human Endothelia Circulation, April 4, 2000; 101(13): 1594 - 1597. [Abstract] [Full Text] [PDF]

				R. K. Dubey, E. K. Jackson, D. G. Gillespie, L. C. Zacharia, B. Imthurn, and P. J. Keller Clinically Used Estrogens Differentially Inhibit Human Aortic Smooth Muscle Cell Growth and Mitogen-Activated Protein Kinase Activity Arterioscler Thromb Vasc Biol, April 1, 2000; 20(4): 964 - 972. [Abstract] [Full Text] [PDF]